Metabolic Disease
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
| 10+ min read
GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity, but they come with side effects. Physicians say the benefits outweigh the risks.
| 4 min read
Targeting a gut bacterial species or its metabolites could potentially improve diabetes management by reducing sugar preferences.
| 3 min read
Sagimet’s denifanstat delivered significant improvements in disease activity and fibrosis for patients with metabolic dysfunction-associated steatohepatitis.
| 3 min read
Injectable micelles that release glucagon could provide a new way to treat hypoglycemic events in diabetes.
| 10 min read
Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.
| 2 min read
AMSBIO has launched a glucagon-like peptide 1 receptor (GLP-1R) reporter cell line.
| 3 min read
Specialized cells in omental adipose tissue may repress fat cell development.
| 5 min read
Paolo Martini leads the biotech company’s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.
| 10 min read
With some out-of-the-box engineering, researchers have developed a nature-inspired strategy to turn sugar in packaged foods into gut-healthy fiber.
| 8 min read
Scientists have appreciated the roles of bacteria in our microbiomes for decades. Now, they’re studying the effects of the trillions of viruses that call the human body home.
| 3 min read
High resolution microscopy revealed distinct mitochondrial populations in inner ear hair cells, setting the stage for probing their role in mitochondrial deafness.
